• Numinus Wellness Inc. (NUMI) has entered into an agreement with Eight Capital and Canaccord Genuity Corp. (underwriters)
  • The underwriters have agreed to purchase, on a bought deal basis an aggregate of 28 million units at a price of C$1.25 per unit for gross proceeds of C$35 million
  • Units consist of one common share and one-half of one common share purchase warrant
  • The offering is expected to close on March 18, 2021
  • Numinus Wellness Inc. is a mental health and wellness company
  • Numius Wellness Inc. (NUMI) is down 14.29 per cent, trading at C$1.20 per share at 11:10 am ET

Numinus Wellness Inc. (NUMI) has entered into an agreement with Eight Capital and Canaccord Genuity Corp. 

The underwriters have agreed to purchase, on a bought deal basis an aggregate of 28 million units at a price of $1.25 per unit.

Aggregate gross proceeds total C$35 million.

Units consist of one common share and one-half of one common share purchase warrant.

Each warrant shall be exercisable to acquire one common share for a period of 24 months from the closing of the offering at an exercise price of $1.75.

The company has granted the Underwriters an option to purchase up to an additional  4,200,000 units at the offering price, exercisable at any time, for a period of 30 days after and including the closing date.

Full exercise of the over-allotment option would result in additional proceeds of up to C$5.25 million 

The offering is expected to close on March 18, 2021 and is subject to certain conditions including all necessary regulatory and stock exchange approvals.

Proceeds will be used for working capital and general corporate purposes.

Numinus Wellness Inc. is a mental health and wellness company.

Numius Wellness Inc. (NUMI) is down 14.29 per cent, trading at C$1.20 per share at 11:10 am ET.

More From The Market Online

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.